OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art review
Vahid Moradi, Elnaz Khodabandehloo, Mehdi Alidadi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 8
Vahid Moradi, Elnaz Khodabandehloo, Mehdi Alidadi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 8
Showing 8 citing articles:
Novel gene manipulation approaches to unlock the existing bottlenecks of CAR-NK cell therapy
Fatemeh Dehghan, Yekta Metanat, Mandana Askarizadeh, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
Fatemeh Dehghan, Yekta Metanat, Mandana Askarizadeh, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
The paths toward immunotherapy of esophageal cancer: An overview of clinical trials
Azfar Jamal, Allolo D Aldreiwish, Saeed Banawas, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114261-114261
Closed Access
Azfar Jamal, Allolo D Aldreiwish, Saeed Banawas, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114261-114261
Closed Access
Is there a place for engineered immune cell therapies in autoimmune diseases?
Luca Perico, Federica Casiraghi, Ariela Benigni, et al.
Trends in Molecular Medicine (2025)
Closed Access
Luca Perico, Federica Casiraghi, Ariela Benigni, et al.
Trends in Molecular Medicine (2025)
Closed Access
Advances in targeting cancer epigenetics using CRISPR-dCas9 technology: A comprehensive review and future prospects
Jeevitha Rajanathadurai, Elumalai Perumal, Jospin Sindya
Functional & Integrative Genomics (2024) Vol. 24, Iss. 5
Closed Access | Times Cited: 4
Jeevitha Rajanathadurai, Elumalai Perumal, Jospin Sindya
Functional & Integrative Genomics (2024) Vol. 24, Iss. 5
Closed Access | Times Cited: 4
Potential alternatives to αβ-T cells to prevent graft-versus-host disease (GvHD) in allogeneic chimeric antigen receptor (CAR)-based cancer immunotherapy: A comprehensive review
Chaozhi Tang, Yuling Zhang
Pathology - Research and Practice (2024) Vol. 262, pp. 155518-155518
Closed Access | Times Cited: 3
Chaozhi Tang, Yuling Zhang
Pathology - Research and Practice (2024) Vol. 262, pp. 155518-155518
Closed Access | Times Cited: 3
Combining the induced pluripotent stem cell (iPSC) technology with chimeric antigen receptor (CAR)-based immunotherapy: recent advances, challenges, and future prospects
Mehdi Alidadi, Haniyeh Barzgar, Mohammad Asif Zaman, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 3
Mehdi Alidadi, Haniyeh Barzgar, Mohammad Asif Zaman, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 3
Focusing on exosomes to overcome the existing bottlenecks of CAR-T cell therapy
Siheng Zhang, Linglong Peng, Yifei Chen, et al.
Inflammation and Regeneration (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 1
Siheng Zhang, Linglong Peng, Yifei Chen, et al.
Inflammation and Regeneration (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 1
Gene Therapy
Pedram Moeini, Gloria González‐Aseguinolaza
Topics in medicinal chemistry (2024)
Closed Access
Pedram Moeini, Gloria González‐Aseguinolaza
Topics in medicinal chemistry (2024)
Closed Access
